These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39084211)

  • 21. Establishing Neural Organoid Cultures for Investigating the Effects of Microgravity in Low-Earth Orbit (LEO).
    Pirjanian NA; Kalpana K; Kruglikov I; Mesci P; Stoudemire J; Grisanti P; Noggle SA; Loring JF; Fossati V
    Methods Mol Biol; 2024 May; ():. PubMed ID: 38801498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids.
    Tamaki Y; Ross JP; Alipour P; Castonguay CÉ; Li B; Catoire H; Rochefort D; Urushitani M; Takahashi R; Sonnen JA; Stifani S; Dion PA; Rouleau GA
    PLoS Genet; 2023 Feb; 19(2):e1010606. PubMed ID: 36745687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice.
    Ke YD; van Hummel A; Au C; Chan G; Lee WS; van der Hoven J; Przybyla M; Deng Y; Sabale M; Morey N; Bertz J; Feiten A; Ippati S; Stevens CH; Yang S; Gladbach A; Haass NK; Kril JJ; Blair IP; Delerue F; Ittner LM
    Neuron; 2024 Apr; 112(8):1249-1264.e8. PubMed ID: 38366598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling.
    Dutta K; Thammisetty SS; Boutej H; Bareil C; Julien JP
    J Neurosci; 2020 Jun; 40(26):5137-5154. PubMed ID: 32457070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.
    Sjögren M; Davidsson P; Wallin A; Granérus AK; Grundström E; Askmark H; Vanmechelen E; Blennow K
    Dement Geriatr Cogn Disord; 2002; 13(2):112-8. PubMed ID: 11844893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
    Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
    EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shared Molecular Mechanisms in Alzheimer's Disease and Amyotrophic Lateral Sclerosis: Neurofilament-Dependent Transport of sAPP, FUS, TDP-43 and SOD1, with Endoplasmic Reticulum-Like Tubules.
    Muresan V; Ladescu Muresan Z
    Neurodegener Dis; 2016; 16(1-2):55-61. PubMed ID: 26605911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers.
    Akiyama T; Koike Y; Petrucelli L; Gitler AD
    Clin Transl Med; 2022 May; 12(5):e818. PubMed ID: 35567447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylated NF-κB subunit p65 aggregates in granulovacuolar degeneration and neurites in neurodegenerative diseases with tauopathy.
    Yamaguchi Y; Ayaki T; Li F; Tsujimura A; Kamada M; Ito H; Maki T; Sawamoto N; Urushitani M; Takahashi R
    Neurosci Lett; 2019 Jun; 704():229-235. PubMed ID: 30946927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KCNJ2 inhibition mitigates mechanical injury in a human brain organoid model of traumatic brain injury.
    Lai JD; Berlind JE; Fricklas G; Lie C; Urenda JP; Lam K; Sta Maria N; Jacobs R; Yu V; Zhao Z; Ichida JK
    Cell Stem Cell; 2024 Apr; 31(4):519-536.e8. PubMed ID: 38579683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteome architecture of human-induced pluripotent stem cell-derived three-dimensional organoids as a tool for early diagnosis of neuronal disorders.
    Negi R; Srivastava A; Srivastava AK; Pandeya A; Vatsa P; Ansari UA; Pant AB
    Indian J Pharmacol; 2023; 55(2):108-118. PubMed ID: 37313936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
    Jovičić A; Paul JW; Gitler AD
    J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer disease pathology in amyotrophic lateral sclerosis.
    Hamilton RL; Bowser R
    Acta Neuropathol; 2004 Jun; 107(6):515-22. PubMed ID: 15024584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discriminative capacity of CSF β-amyloid 42 and Tau in neurodegenerative diseases in the Chinese population.
    Ye LQ; Li XY; Zhang YB; Cheng HR; Ma Y; Chen DF; Tao QQ; Li HL; Wu ZY
    J Neurol Sci; 2020 May; 412():116756. PubMed ID: 32142967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.
    Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL
    Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lost in Translation: Evidence for Protein Synthesis Deficits in ALS/FTD and Related Neurodegenerative Diseases.
    Lehmkuhl EM; Zarnescu DC
    Adv Neurobiol; 2018; 20():283-301. PubMed ID: 29916024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinflammation-Related Proteins NOD2 and Spp1 Are Abnormally Upregulated in Amyotrophic Lateral Sclerosis.
    de Luna N; Carbayo Á; Dols-Icardo O; Turon-Sans J; Reyes-Leiva D; Illan-Gala I; Jericó I; Pagola-Lorz I; Lleixà C; Querol L; Rubio-Guerra S; Alcolea D; Fortea J; Lleó A; Cortés-Vicente E; Rojas-Garcia R
    Neurol Neuroimmunol Neuroinflamm; 2023 Mar; 10(2):. PubMed ID: 36460480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43.
    Godoy-Corchuelo JM; Ali Z; Brito Armas JM; Martins-Bach AB; García-Toledo I; Fernández-Beltrán LC; López-Carbonero JI; Bascuñana P; Spring S; Jimenez-Coca I; Muñoz de Bustillo Alfaro RA; Sánchez-Barrena MJ; Nair RR; Nieman BJ; Lerch JP; Miller KL; Ozdinler HP; Fisher EMC; Cunningham TJ; Acevedo-Arozena A; Corrochano S
    Neurobiol Dis; 2024 Apr; 193():106437. PubMed ID: 38367882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.